Meditope Biosciences is actively seeking strategic partnerships to discover and develop next generation antibody therapies. These partnerships will allow us to not only expand the application of our SnAP technology, but also better enable us to advance our IO products bringing much needed therapies to patients worldwide.
Multiple collaboration opportunities exist including:
Traditional discovery and development collaborations
Co-development partnerships on our lead IO product candidates - MeKine and MeCAR
Licensing partnering opportunities - Platform licensing for non-therapeutic application